A clinical stage T cell immunotherapy company developing products to target cancer, infectious and autoimmune diseases
Oxford, England
Joined January 2019
- Tweets372
- Following146
- Followers878
- Likes390
Pinned Tweet
#NEWS: Vaccitech is now @BarinthusBio! Listen to CEO, @benrights, explain the meaning behind our new name. Learn more: bit.ly/47ny6nR #innovation #immunotherapy
Vaccitech retweeted
Graham Griffiths of @Vaccitechplc discusses lessons from #vaccine and drug development during the pandemic, as well as the importance of collaboration in #pandemic preparedness. Read more:
europeanpharmaceuticalreview…
#DrugDevelopment #EPRTalks
Congratulations to the team for the publication of their paper in Vaccines journal! Respiratory syncytial virus (#RSV) infection and #shingles are two viral diseases that affect older adults - read the full paper here: mdpi.com/2076-393X/11/11/167…
#biotech #innovation
Learn more about our #prostatecancer multi-platform approach immunotherapeutic candidate, VTP-850, currently in phase 1/2 clinical trials: bit.ly/3LQPE2p $VACC
Our CEO, @benrights was recently profiled by @YoungBiotech. He talks about his 30+ years in both privately held and publicly traded companies and explains how part of his career felt like “indoctrination by fire.” Read more here: futurebiotechnologists.org/i… $VACC
.@contagion_live recently spoke with CSO Nadege Pelletier, discussing our HBV immunotherapeutic candidate, VTP-300, and the work towards a component for functional cure for #hepatitisB: contagionlive.com/view/utili…
$VACC #womeninbiotech
.@Vaccitechplc has developed an immunotherapy platform to provide a functional cure for HBV. #hepatitis b #livertwitter
contagionlive.com/view/utili…
Middle East Respiratory Syndrome (MERS) is a viral respiratory illness that is transferred to humans from infected dromedary camels and has the potential to pose a #pandemic threat - it's great to see @PSIOxford pushing this research forward!
📢 NEWS: Scientists from Oxford & Liverpool launch new vaccine trial for Middle East Respiratory Syndrome (MERS).
#MERS is a deadly viral illness with no current vaccines, posing a potential #pandemic threat.
Read the full story ⬇️
psi.ox.ac.uk/news/oxford-and…
ALT Clinician administering a vaccine to a female patient
Join us for a webinar on September 20th featuring world experts in #hepatitisB, Dr. @EleanorBarnesOx & Dr. Ed Gane. They'll discuss progress being made in HBV treatments, like combination approaches to enhancing rates of functional cure: bit.ly/45VyXf2
$VACC #meded
Our CEO @benrights recently penned an article in @Biospace discussing how Vaccitech has built a global #biopharma presence on both sides of the pond. Read more: biospace.com/article/opinion…
$VACC
We’re looking forward to sitting down for a fireside chat today at this year’s @MorganStanley Annual Global Healthcare Conference at 11:30am ET in New York City. We look forward to seeing you there!
#investors #biotech $VACC
#DYK Only 30% of people with #celiac are properly diagnosed. bit.ly/3LQPE2p #NationalCeliacDiseaseAwarenessDay
International #HepB experts Drs. @EleanorBarnesOx & Ed Gane, will participate in our #keyopinionleader webinar next week discussing the current treatment landscape and the potential of an antigen-specific immunotherapeutic approach. Register here: brnw.ch/21wCt54 $VACC
Join us on September 20th at 2pm ET for a KOL Webinar with @Vaccitechplc ( $VACC ), featuring Dr. Eleanor Barnes and Dr. Ed Gane, discussing #HBV and the potential of the antigen-specific immunotherapeutic approach.
RSVP: brnw.ch/21wCt51
We’re looking forward to presenting today at this year’s H.C. Wainwright Annual Global Investment Conference in New York City. Join us in person or virtually today at 09:30am to learn more: journey.ct.events/view/b7306…
#biotech #immunotherapy $VACC #investorconference #investors
Tomorrow! Our CEO @benrights will be speaking about #organizationaldesign with an array of business leaders across diverse sectors. Click the link below👇 to sign up for the webinar hosted by @CultureWorksLPD. $VACC
#DYK that prostate cancer is the second most common cancer among men? About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Learn more about risk factors and screening: cancer.org/cancer/types/pros… #ProstateCancerAwarenessMonth.
#DYK we’re on both sides of the pond? Vaccitech’s U.S. office, located in Germantown, MD, is designed to enable the research and development programs in #polymerdrug delivery, as well as advancement of the SNAPvax team: investors.vaccitech.co.uk/ $VACC
Vaccitech retweeted
Discover how to strategically reshape your company's culture for growth with insights from Bill Enright (Vaccitech) & Andrew Lee (888Africa & Voxbet) as well as our CEO Michael Short and Associate Guy Pearson.
Our HBV candidate, VTP-300, is the first antigen-specific #immunotherapy that’s been shown to induce sustained reductions in #HepatitisB surface antigen. Innovative research like this offers hope to those with chronic HBV.
Learn more: bit.ly/3CBGanB
$VACC
